Sensulin LLC
Sensulin LLC is developing a true once-a-day glucose-responsive insulin that may mimic a healthy human pancreas.
Venture group established as a funding mechanism for spinouts from Accele Biopharma Inc.
Arthrokinex is a comprehensive joint health program that can reduce or eliminate joint pain from osteoarthritis through the healing powers of the patient’s own blood without complications.
Biolytx’s core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those resistant to current antibiotics.
Charlesson, an Oklahoma-based pharmaceutical company, is actively engaged in the development of therapeutics for treating debilitating ophthalmic diseases. Their product pipeline includes pharmaceutical treatments for Age-Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammation, Angiogenesis, and systemic diabetes.
COARE Biotechnology is a research driven pharmaceutical company dedicated to developing novel therapeutic agents designed to treat solid tumor cancers.
Crescendo Bioscience is a molecular diagnostics laboratory focused on rheumatology.
Cytovance Biologics is a biopharmaceutical contract manufacturer of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation.
DormaTarg is a pharmaceutical company developing a series of small molecule oncology therapeutics that inhibit recurrence in metastasis prone cancers, with an initial focus on Triple Negative Breast Cancer.
Drik is a pre clinical toxicology services laboratory for drug safety evaluation. They do preclinical screening tests for cosmetic industry and non clinical toxicology testing for chemical manufacturing.
EKIPS Technologies utilizes mid-IR laser technology to rapidly measusre subparts per billion concentrations of nitric oxide (NO).
EpimedX, LLC is an Oklahoma-based biotechnology company with the mission to develop Gene Regulation Therapy ? a promising technology that is expected to provide a safe, cost-effective and permanent treatment for sickle cell disease, beta-thalassemia and malaria without dangerous or harmful side effects.
Hyalose, LLC is a biotechnology company focused on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HA), an important biomolecule for many healthcare and cosmetic applications.
IMMY delivers diagnostics that can be performed without high-technology laboratory equipment or even electricity in general.
Jortan is developing a novel approach to the treatment of Type-2 diabetes.
Mintiva develops products specially formulated for distinct topical applications.
Moleculera Labs provides personalized clinical testing services for individuals suspected of suffering from PANDAS/PANS, which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders (OCD) and sometimes Autism Spectrum Disorders.
Oklahoma Medical Research Foundation has developed a highly effective and safe therapeutic for the treatment of glioblastoma. The compound, OKN-007, has the unique ability to cross the blood-brain barrier and has been successfully shown to decrease both tumor size and tumor vasculature in animal models of glioblastoma.
Otologic Pharmaceutics, Inc. (OP) is an Oklahoma-headquartered organization formed specifically to commercialize promising technologies that address novel pharmacological solutions for hearing and balanced health.
Pamlico BioPharma develops fully-human antibody therapeutics for infectious diseases.
PolySkope Labs provides the best service and offers the?most advanced technology in the food safety industry.
